Literature DB >> 16645482

The role of bacteria in airway inflammation in exacerbations of chronic obstructive pulmonary disease.

Timothy F Murphy1.   

Abstract

PURPOSE OF REVIEW: Bacteria cause approximately half of all chronic obstructive pulmonary disease exacerbations. The purpose of this review is to evaluate the status of research on the role of bacteria in airway inflammation during exacerbations and the mechanisms by which bacterial antigens induce inflammation. RECENT
FINDINGS: Bacteria in the airways of adults with chronic obstructive pulmonary disease release antigens including endotoxin, peptidoglycan fragments, lipoproteins, and other molecules into the airways. These bacterial antigens induce potent inflammatory effects in the airways. Bacterial exacerbations are associated with systemic inflammation. Studies of Haemophilus influenzae, the most common bacterial cause of exacerbations, reveal that strains associated with exacerbations induce more inflammation compared to colonizing strains. H. influenzae antigens induce production of interleukin-8 and tumor necrosis factor-alpha, activate Toll-like 2 receptors, activate NFkappaB and p38 mitogen-activated protein signaling pathways, and have other inflammatory effects.
SUMMARY: Research on the role of bacteria in causing inflammation in chronic obstructive pulmonary disease has been neglected for decades. Research should be directed at further evaluating the role of bacterial antigens in airway inflammation. Reducing or modulating bacterial infection of the airways in chronic obstructive pulmonary disease has the potential to reduce airway inflammation by eliminating an important inciting cause.

Entities:  

Mesh:

Year:  2006        PMID: 16645482     DOI: 10.1097/01.qco.0000224815.89363.15

Source DB:  PubMed          Journal:  Curr Opin Infect Dis        ISSN: 0951-7375            Impact factor:   4.915


  29 in total

1.  TGF-beta induces p65 acetylation to enhance bacteria-induced NF-kappaB activation.

Authors:  Hajime Ishinaga; Hirofumi Jono; Jae Hyang Lim; Soo-Mi Kweon; Haodong Xu; Un-Hwan Ha; Haidong Xu; Tomoaki Koga; Chen Yan; Xin-Hua Feng; Lin-Feng Chen; Jian-Dong Li
Journal:  EMBO J       Date:  2007-02-01       Impact factor: 11.598

2.  Cigarette smoke exposure exacerbates lung inflammation and compromises immunity to bacterial infection.

Authors:  Amit A Lugade; Paul N Bogner; Thomas H Thatcher; Patricia J Sime; Richard P Phipps; Yasmin Thanavala
Journal:  J Immunol       Date:  2014-04-21       Impact factor: 5.422

3.  Synergistic activation of NF-kappaB by nontypeable H. influenzae and S. pneumoniae is mediated by CK2, IKKbeta-IkappaBalpha, and p38 MAPK.

Authors:  Soo-Mi Kweon; Beinan Wang; Davida Rixter; Jae Hyang Lim; Tomoaki Koga; Hajime Ishinaga; Lin-Feng Chen; Hirofumi Jono; Haidong Xu; Jian-Dong Li
Journal:  Biochem Biophys Res Commun       Date:  2006-10-17       Impact factor: 3.575

Review 4.  Airway epithelial stem cells and the pathophysiology of chronic obstructive pulmonary disease.

Authors:  Scott H Randell
Journal:  Proc Am Thorac Soc       Date:  2006-11

5.  C-reactive protein measurements as a marker of the severity of chronic obstructive pulmonary disease exacerbations.

Authors:  Gulistan Karadeniz; Gulru Polat; Gunes Senol; Melih Buyuksirin
Journal:  Inflammation       Date:  2013-08       Impact factor: 4.092

6.  Presence of copper- and zinc-containing superoxide dismutase in commensal Haemophilus haemolyticus isolates can be used as a marker to discriminate them from nontypeable H. influenzae isolates.

Authors:  W W Mary Fung; Clíona A O'Dwyer; Sunita Sinha; Aimee L Brauer; Timothy F Murphy; J Simon Kroll; Paul R Langford
Journal:  J Clin Microbiol       Date:  2006-09-20       Impact factor: 5.948

Review 7.  Heterogeneity of chronic obstructive pulmonary disease: from phenotype to genotype.

Authors:  Xu Chen; Xiaomao Xu; Fei Xiao
Journal:  Front Med       Date:  2013-12       Impact factor: 4.592

8.  RelB is differentially regulated by IkappaB Kinase-alpha in B cells and mouse lung by cigarette smoke.

Authors:  Se-Ran Yang; Hongwei Yao; Saravanan Rajendrasozhan; Sangwoon Chung; Indika Edirisinghe; Samantha Valvo; George Fromm; Michael J McCabe; Patricia J Sime; Richard P Phipps; Jian-Dong Li; Michael Bulger; Irfan Rahman
Journal:  Am J Respir Cell Mol Biol       Date:  2008-08-07       Impact factor: 6.914

9.  EVI1 acts as an inducible negative-feedback regulator of NF-κB by inhibiting p65 acetylation.

Authors:  Xiangbin Xu; Chang-Hoon Woo; Rachel R Steere; Byung Cheol Lee; Yuxian Huang; Jing Wu; Jinjiang Pang; Jae Hyang Lim; Haidong Xu; Wenhong Zhang; Anuhya S Konduru; Chen Yan; Michael T Cheeseman; Steve D M Brown; Jian-Dong Li
Journal:  J Immunol       Date:  2012-05-11       Impact factor: 5.422

Review 10.  Emerging facets of prokaryotic glycosylation.

Authors:  Christina Schäffer; Paul Messner
Journal:  FEMS Microbiol Rev       Date:  2016-08-26       Impact factor: 16.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.